Outcome of kidney transplantation with Bricker-type ureterointestinal anastomosis in patients with lower urinary tract dysfunction.

ISRCTN ISRCTN23941498
DOI https://doi.org/10.1186/ISRCTN23941498
Secondary identifying numbers N/A
Submission date
01/11/2014
Registration date
26/01/2015
Last edited
15/10/2020
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Urological and Genital Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English Summary

Background and study aims
Kidney transplantation is the best treatment for kidney failure but for patients with lower urinary tract (bladder and urethra) dysfunction (for example, due to an infection), it is often impossible perform that surgery in a classic way. A Bricker-type ureterointestinal anastomosis (a tube connecting the ureter to the small intestine) is a widely used technique for performing ureteroenteric anastomosis (a technique for diverting the flow of urine from its normal route) in these cases. Here, we want to investigate how well patients do having undergone a Bricker-type ureterointestinal anastomosis during their kidney transplant compared to patients who have a classic kidney transplant

Who can participate?
Adults (aged 20-64) with lower urinary tract dysfunction that underwent a kidney transplantation with Bricker-type ureterointestinal anastomosis from 1999 to 2014 (experimental group). A control group consisting of participants who have had a classic kidney transplant, receiving either the second kidney of a deceased donor from which a participant from the experimental group has been given the first, or a kidney from a living donor is also recruited. In the case of patients whose kidney is from living donor, comparisons are made with people in the experimental group who have also received a kidney from a living donor.

What does the study involve?
Participants are invited to our hospital, where they undergo an examination and a number of tests (blood tests, urine tests, ultrasound, renal scintigraphy). The results from the experimental group are then compared to those of the control group.

What are the possible benefits and risks of participating?
All participants will be given the results of our tests. If we find some disorders or abnormalities we will try to treat them. The risk to participants is close to zero.

Where is the study run from?
Department of General and Transplantation Surgery of Infant Jesus Hospital in Warsaw (Poland)

When is the study starting and how long is it expected to run for?
November 2014 to September 2015.

Who is funding the study?
Medical University of Warsaw (Poland)

Who is the main contact?
Agnieszka Jóźwik
agniechaaj@gmail.com

Contact information

Miss Agnieszka Jóźwik
Scientific

Nowogrodzka 59
Warsaw
02-006
Poland

Study information

Study designObservational single-centre trial
Primary study designObservational
Secondary study designSingle-centre
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleOutcome of kidney transplantation with Bricker-type ureterointestinal anastomosis in patients with lower urinary tract infection: a observational single-centre trial
Study acronymN/A
Study hypothesisStudy hypothesis is that outcome of kidney transplantation with Bricker-type ureterointestinal anastomosis, is as good as outcome of kidney transplantation with normal urinary drainage. There is the same kidney function, number of complications after transplantation, graft and patient survival.
Ethics approval(s)Bioethical Committee of Medical University of Warsaw, 04/11/2014, ref. KB/215/2014
ConditionPatients with end stage renal disease and lower urinary tract dysfunction who underwent kidney transplantation with Bricker-type ureterointestinal anastomosis in our center.
InterventionWe will compare results of the following for experimental and control group patients:
1. Blood tests
2. Urine tests
3. Ultrasound
4. Renal scintigraphy
5. eGFR (creatinine clearace, Cocroft-Gault formula, MDRD formula, CKD - EPI formula)
Intervention typeOther
Primary outcome measure1. Blood tests: complete blood count, sodium, potassium, chloride, bicarbonate, blood urea nitrogen, magnesium, creatinine, glucose, calcium, lipid profile, cystatin C, C Reactive Protein, AST, ALT, bilirubin, serum albumin, vitamin B12, folic acid, transferrin, ferritin, parathormone.
2. Urine tests: routine and microscopy, cretinine, bacterial cultures.
3. Ultrasound of the abdomen and graft.
4. Renal scintigraphy.
Secondary outcome measuresN/A
Overall study start date12/11/2014
Overall study end date30/09/2015

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants74 (37 patients that have undergone kidney transplantation with Bricker-type ureterointestinal anastomosis and 37 patients that have undergone kidney transplantation with normal urinary drainage).
Participant inclusion criteria1. Patients with lower urinary tract dysfunction who underwent kidney transplantation with Bricker-type ureterointestinal anastomosis at study center, from 1999 to 2014 (experimental group)
2. Age range 20 to 64
3. Control group - patients who had kidney transplantation and obtained a kidney from the same deceased donor as a participant from the experimental group.
4. In the case of patients, who have received a kidney from a living donor, comparisons between control and experimental group participants will be made with others that have recieved a kidney from a living donor.
Participant exclusion criteriaPatients who refuse their participation in this study.
Recruitment start date12/11/2014
Recruitment end date30/09/2015

Locations

Countries of recruitment

  • Poland

Study participating centre

Nowogrodzka 59
Warsaw
02-006
Poland

Sponsor information

Medical University of Warsaw (Poland)
University/education

Żwirki i Wigury 61
Warsaw
02-091
Poland

ROR logo "ROR" https://ror.org/04p2y4s44

Funders

Funder type

University/education

Medical University of Warsaw (Poland)
Government organisation / Local government
Alternative name(s)
Medical University of Warsaw
Location
Poland

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Editorial Notes

15/10/2020: No publications found.